European Review of Dermatology (ERD)

Executive Summary

Skin disease is a common complaint which affects 1 in 4 individuals at any given time. In Europe, although the prevalence of skin disease is common, no comprehensive surveys are available. However surveys across individual countries suggest there is a huge unmet dermatological need. For instance a recent survey of adults in London suggested 22.5% had a skin disease that could benefit from treatment but only 24% of such individuals actively sought medical advice in the last 6 months (Rea JN, Newhouse ML, et al. Skin disease in Lambeth: a community study of prevalence and use of medical care. Br J Prev Soc Med 1976; 30: 107-14).

With an aging population and consumers of healthcare becoming generally more aware of their options, this unmet need is likely to increase. Compounded with the rise in the number of economic migrants and frequent travel across borders, infectious skin and venereal disease will most likely add to this unmet need over the course of the next 2 decades.

Within Europe there is a big difference in the provision of dermatological services from one country to another and the debate on optimal dermatological care for each particular country will continue. The European Review of Dermatology aims to address key issues and is intended to inform and educate clinicians with a series of thought provoking, comprehensive and well balanced articles written by key thought leaders, leading doctors and leading authorities, addressing the most important and salient developments in the field of dermatology. It will provide an in-depth analysis and overview of the European Dermatology industry, focusing on the most recent developments in addressing unmet needs in a variety of disorders which include:

The report will serve as a source of information for a targeted audience and support physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity. The editorial policy has been designed to encourage discussion among this peer group. The publication contains independently commissioned clinical and scientific editorial from the principal thought leaders and key opinion leaders from within the European dermatology sector.

Thought Leader Collaboration

European Review of Dermatology draws on the expertise of key opinion leaders within the European Dermatology industry to ensure that it delivers world-class reviews into the key developments and advancements within this vital clinical area. Thought leaders and organisations who are being invited to contribute to the publication include:

Editorial Contributors

Supporting Organisations

ESCAD

ESCADESCAD is a democratic, non-commercial, non-profit making medical scientific Learned Society, which is registered in Paris. ESCAD is supported by a scientific committee which includes many members from Europe and a good number of colleagues from other continents. ESCAD cooperates with other international and national cosmetic dermatological societies. The society aims to foster the highest standards of patient care in cosmetic and aesthetic dermatology, and aims to facilitate continuing professional development and a friendly forum for the exchange of scientific research and innovative techniques. ESCAD tries to bring together clinical dermatologists, academic dermatologists, and scientists working in the pharmaceutical and cosmetic industries.

In July 2000, in Cannes, France, ESCAD held its first independent congress, a 3-day meeting entitled osmoderm. The success of this meeting has led ESCAD, in association with various other sister societies, to plan a large Cosmoderm meeting each year. Cosmoderm XIV is scheduled to take place in Tel Aviv, 3-4 December 2009. http://www.escad.org/

International Academy of Cosmetic Dermatology

International Academy of Cosmetic DermatologySince its inception a decade ago, the International Academy of Cosmetic Dermatology has matured into a major force in the rapidly growing field of cosmetic dermatology. The IACD continues to foster the cooperation of physicians interested in the aesthetic aspects of medicine and the members of the pharmaceutical and cosmetic industries. This has placed the IACD on a strong foothold in the sphere of cosmetic dermatology.

The purpose of our academy is to bring together dermatologists and cosmetic surgeons with members of the pharmaceutical and cosmetic industry. Cosmetic and pharmaceutical chemists will have the opportunity for an open and free interchange with physicians in an atmosphere conducive to learning. Membership in the International Academy of Cosmetic Dermatology is open to physicians with an interest in cosmetic dermatology and to members of the pharmaceutical and cosmetic industry who share similar goals. www.iacdworld.org/

Circulation & Readership

The key to the success of European Review of Dermatology is the quality of the circulation which covers the European primary and secondary care market. The distribution includes:

Copies of European Review of Dermatology will be distributed in both print and electronic format to.

  • General Dermatologists
  • Immunodermatologists
  • Pediatric Dermatologists
  • Dermatopathologists
  • Aesthetic & Cosmetic Dermatologists
  • Wound Management Specialists
  • Primary Care Physicians
  • Dermatology Nurse practitioners
  • Rheumatologists
  • Clinicians
  • Allergists
  • Professional Skin Care Specialists
  • Dermatologic Surgeons

Proposed Geographical Breakdown

Germany
France
UK
Italy
Spain
Scandinavia
Eastern Europe
Benelux
Portugal
Other		 19%
17%
17%
13%
12%
7%
6%
3%
3%
3%

Copies of European Review of Dermatology will be distributed at a number of key events including:

18th Congress of EADV ICC (October 2009, Berlin)

EMAA 2009 (October 2009, Paris)

39th Annual ESDR Meeting (September 2009, Budapest)

Package

We are able to provide you with:

Benefits

Rate Card

Support the development of one independent article:

£16,000

Support the development of two independent articles:

£28,000

Support the development of three independent articles:

 £40,000

There is an option to recommend authors and topics

PROMOTIONAL MEDIA RATES

Single page colour:

£5,000

Double page colour:

£16,000

Prime inside front colour:

 £9,950

Inside back colour:

 £9,950
Sovereign Publications is committed to the observance of the regulations that govern the promotion of medicines and the support of scientific and educational material and as such, Sovereign requests support from companies, companies never approach us. We assure that the content will be educational and non-promotional in nature, and will be planned, designed and implemented in accordance with European Codes of Practice (ABPI, IFPMA, EFPI ). Authors are independently commissioned by Sovereign and there is no scientific bias in the content published. Support from your company will be clearly and prominently disclosed. Financial support of Sovereign content is never perceived as an inducement to healthcare professionals to prescribe or recommend a particular medicine or course of treatment.